1-3 of 3
Kay Noel, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Genetic Factors Predicting The Response To BET Bromodomain Inhibitors In Lymphoma Lead To New Synergistic Combinations

Eugenio Gaudio, PhD, Ivo Kwee, PhD, Andrea Rinaldi, PhD, Michela Boi, PhD, Elena Bernasconi, B.Sc., Monica Testoni, B.Sc., Anastasios Stathis, MD, Patrice Herait, MD, Kay Noel, PhD, Giorgio Inghirami, Emanuele Zucca, MD, Francesco Bertoni, MD
Journal: Blood
Blood (2013) 122 (21): 3070.
https://doi.org/10.1182/blood.V122.21.3070.3070
Published: 2013
Journal Articles

The Brd-Inhibitor OTX015 Is Active in Pre-Clinical Models of Mature B-Cell Lymphoid Tumors

Paola Bonetti, PhD, Michela Boi, Maurilio Ponzoni, Maria Grazia Tibiletti, Anastasios Stahis, Giorgio Inghirami, Kay Noel, PhD, Emanuele Zucca, MD, Francesco Bertoni, MD
Journal: Blood
Blood (2012) 120 (21): 1657.
https://doi.org/10.1182/blood.V120.21.1657.1657
Published: 2012
Journal Articles

Clinical Outcomes and Cost of Outpatient Community-Based Treatment for Rituximab Refractory Non-Hodgkins Lymphoma (NHL) Patients.

Andrew D. Zelenetz, MD, PhD, Boxiong Tang, MD, PhD, Diana Frame, Luba Nalysnyk, MD, MPH, Catherine Cella, J. Kay Noel, PhD
Journal: Blood
Blood (2004) 104 (11): 3132.
https://doi.org/10.1182/blood.V104.11.3132.3132
Published: 2004